Media Summary: Commissioner of Food and Drugs, Robert M. Califf MD, MACC, delivers his Keynote Address to the 2023 Dr. Janet Woodcock, MD, acting Commissioner of Food and The purpose of this public workshop is to communicate how FDA's

Advancing Generic Drugs Development Translating - Detailed Analysis & Overview

Commissioner of Food and Drugs, Robert M. Califf MD, MACC, delivers his Keynote Address to the 2023 Dr. Janet Woodcock, MD, acting Commissioner of Food and The purpose of this public workshop is to communicate how FDA's Lei Zhang, PhD, Deputy Director for the Office of Regulatory Science, delivers closing remarks to conclude day one of the ... Robert Lionberger, PhD, Director for the Office of Regulatory Science, delivers closing remarks to conclude the This public workshop communicated how FDA's

This workshop focused on common issues seen in abbreviated new

Photo Gallery

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 1 – Part 1
Advancing Generic Drug Development: Translating Science to Approval Keynote Address
Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 2
Advancing Generic Drug Development: Translating Science to Approval, Day One Closing Remarks
Advancing Generic Drug Development: Translating Science to Approval, Day Two Closing Remarks
Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 2
Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 3
Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 1
Advancing Generic Drug Development: Translating Science to Approval – Day 2 – Session 7
Advancing Generic Drug Development: Translating Science to Approval – Day 1 – Session 2
Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 1
Advancing Generic Drug Development: Translating Science to Approval – Day 2 – Session 6
View Detailed Profile
Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 1 – Part 1

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 1 – Part 1

Commissioner of Food and Drugs, Robert M. Califf MD, MACC, delivers his Keynote Address to the 2023

Advancing Generic Drug Development: Translating Science to Approval Keynote Address

Advancing Generic Drug Development: Translating Science to Approval Keynote Address

Dr. Janet Woodcock, MD, acting Commissioner of Food and

Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 2

Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 2

The purpose of this public workshop is to communicate how FDA's

Advancing Generic Drug Development: Translating Science to Approval, Day One Closing Remarks

Advancing Generic Drug Development: Translating Science to Approval, Day One Closing Remarks

Lei Zhang, PhD, Deputy Director for the Office of Regulatory Science, delivers closing remarks to conclude day one of the ...

Advancing Generic Drug Development: Translating Science to Approval, Day Two Closing Remarks

Advancing Generic Drug Development: Translating Science to Approval, Day Two Closing Remarks

Robert Lionberger, PhD, Director for the Office of Regulatory Science, delivers closing remarks to conclude the

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 2

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 2

This public workshop communicated how FDA's

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 3

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 3

This public workshop communicated how FDA's

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 1

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 1

This public workshop communicated how FDA's

Advancing Generic Drug Development: Translating Science to Approval – Day 2 – Session 7

Advancing Generic Drug Development: Translating Science to Approval – Day 2 – Session 7

This workshop focused on common issues seen in abbreviated new

Advancing Generic Drug Development: Translating Science to Approval – Day 1 – Session 2

Advancing Generic Drug Development: Translating Science to Approval – Day 1 – Session 2

This workshop focused on common issues seen in abbreviated new

Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 1

Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 1

The purpose of this public workshop is to communicate how FDA's

Advancing Generic Drug Development: Translating Science to Approval – Day 2 – Session 6

Advancing Generic Drug Development: Translating Science to Approval – Day 2 – Session 6

This workshop focused on common issues seen in abbreviated new

Advancing Generic Drug Development Translating Science to Approval Day 2–Session 8 & Closing Remarks

Advancing Generic Drug Development Translating Science to Approval Day 2–Session 8 & Closing Remarks

This workshop focused on common issues seen in abbreviated new